Beyond the Acute Phase: Long-Term Impact of COVID-19 on Functional Capacity and Prothrombotic Risk—A Pilot Study
暂无分享,去创建一个
C. Adam | L. C. Dima-Cozma | A. Maștaleru | D. Cojocaru | R. Negru | C. Cumpăt | M. Leon | Florin Mitu | Viviana Onofrei | Alexandra Maștaleru
[1] B. Patel,et al. Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States , 2023, Lancet regional health. Americas.
[2] M. Marc,et al. Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study , 2023, Journal of personalized medicine.
[3] Carlos M. Morel,et al. Hematological alterations associated with long COVID-19 , 2023, Frontiers in physiology.
[4] M. Wygrecka,et al. Decoding the role of fatty acids and their metabolites in lung fibrosis. , 2023, Polish archives of internal medicine.
[5] J. Dai,et al. Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy , 2023, Journal of Molecular Medicine.
[6] S. Duong-Quy,et al. Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review , 2023, Pulmonary Therapy.
[7] K. Stark,et al. Thromboinflammation in long COVID—the elusive key to postinfection sequelae? , 2023, Journal of Thrombosis and Haemostasis.
[8] S. Parthasarathy,et al. Long COVID: a review and proposed visualization of the complexity of long COVID , 2023, Frontiers in Immunology.
[9] I. Pavord,et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary , 2023, Respirology.
[10] E. Topol,et al. Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.
[11] P. Durrington. Blood lipids after COVID-19 infection , 2023, The Lancet Diabetes & Endocrinology.
[12] M. Wygrecka,et al. Diverse Functions of Apolipoprotein A-I in Lung Fibrosis. , 2022, American journal of physiology. Cell physiology.
[13] V. Tsampasian,et al. Post-COVID-19 syndrome risk factors and further use of health services in East England , 2022, PLOS global public health.
[14] W. Man,et al. A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae , 2022, Science Translational Medicine.
[15] N. C. Cimşit,et al. New grading system for post-COVID-19 pulmonary fibrosis based on computed tomography findings , 2022, Medicine.
[16] S. Tanni,et al. Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We? , 2022, Archivos de Bronconeumología.
[17] Rui A. Lima,et al. Diagnosis Methods for COVID-19: A Systematic Review , 2022, Micromachines.
[18] X. Wang,et al. Sustained abnormality with recovery of COVID-19 convalescents: a 2-year follow-up study , 2022, Science bulletin.
[19] S. Saydah,et al. Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021 , 2022, Morbidity and Mortality Weekly Report.
[20] I. Mitroulis,et al. Editorial: Platelet Function in COVID-19 , 2022, Frontiers in Cardiovascular Medicine.
[21] Arthur L. Allen,et al. Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum , 2022, Journal of Thrombosis and Thrombolysis.
[22] Laura Schneider,et al. Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults , 2022, Frontiers in Neurology.
[23] J. Gonzales-Zamora,et al. Mean Platelet Volume as a Predictor of COVID-19 Severity: A Prospective Cohort Study in the Highlands of Peru , 2022, Diseases.
[24] V. Novakovic,et al. Persistent Lung Injury and Prothrombotic State in Long COVID , 2022, Frontiers in Immunology.
[25] V. Novakovic,et al. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation , 2022, Frontiers in Cellular and Infection Microbiology.
[26] P. Bonniaud,et al. Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis , 2022, Cells.
[27] C. Fernández‐de‐las‐Peñas,et al. Long COVID: systemic inflammation and obesity as therapeutic targets , 2022, The Lancet Respiratory Medicine.
[28] R. Otero-Candelera,et al. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases , 2022, Archivos de Bronconeumología.
[29] F. Kakamad,et al. Post COVID-19 pulmonary fibrosis; a meta-analysis study , 2022, Annals of Medicine and Surgery.
[30] E. Ponomarev,et al. Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients , 2022, Frontiers in Cardiovascular Medicine.
[31] V. Poletti,et al. European Respiratory Society statement on long COVID follow-up , 2022, European Respiratory Journal.
[32] Benjamin Bowe,et al. Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.
[33] Nelson B Rodrigues,et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis , 2021, Brain, Behavior, and Immunity.
[34] S. Stanojevic,et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests , 2021, European Respiratory Journal.
[35] H. Hackl,et al. Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype , 2021, Frontiers in Cardiovascular Medicine.
[36] A. Zoufaly,et al. Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5 , 2021, Frontiers in Cardiovascular Medicine.
[37] F. Bai,et al. Female gender is associated with long COVID syndrome: a prospective cohort study , 2021, Clinical Microbiology and Infection.
[38] G. Poudel,et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection , 2021, JAMA network open.
[39] S. Tanni,et al. Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification , 2021, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[40] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[41] T. Renné,et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome , 2021, Journal of Thrombosis and Haemostasis.
[42] E. Poveda,et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study , 2021, Scientific Reports.
[43] F. Dioguardi,et al. Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications , 2021, Frontiers in Medicine.
[44] E. Hoffman,et al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length , 2021, Thorax.
[45] A. Fabro,et al. Pulmonary fibrosis secondary to COVID-19: a narrative review , 2021, Expert review of respiratory medicine.
[46] S. Plíšek,et al. Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia , 2021, Virology journal.
[47] A. Bellasi,et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation , 2021, Epidemiology and Infection.
[48] F. Kronenberg,et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial , 2020, European Respiratory Journal.
[49] R. Sutton,et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. , 2020, Clinical medicine.
[50] Arthur S Slutsky,et al. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19 , 2020, Canadian Medical Association Journal.
[51] C. Campèse,et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[52] Kevin McCarthy,et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement , 2019, American journal of respiratory and critical care medicine.
[53] G. Filippatos,et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.
[54] Thomas Kahan,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[55] Bertram L Kasiske,et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). , 2011, Kidney international.
[56] R Merget,et al. Body plethysmography--its principles and clinical use. , 2011, Respiratory medicine.
[57] Kannan Ramar,et al. Updates on definition, consequences, and management of obstructive sleep apnea. , 2011, Mayo Clinic proceedings.
[58] A. Chetta,et al. Reference values for the 6-min walk test in healthy subjects 20-50 years old. , 2006, Respiratory medicine.